Global Kinetics Pty Ltd (GK) is a commercial-stage digital health company revolutionising the management of Parkinson’s disease by providing the first continuous and objective measurement of patients’ symptoms in everyday environments.
The company’s Personal KinetiGraph® system (PKG®) is a patient-friendly, algorithm-based system that records patients’ movements over the course of several days and creates data-driven reports that empowers more personalised treatment and management decisions—ultimately leading to a higher quality of life for patients.
The PKG® system is being used in clinics across the U.S., Europe and Asia Pacific, enabling better clinical outcomes and reducing health care costs across the Parkinson’s disease continuum. Global Kinetics continues to pursue partnerships with major pharmaceutical and medical technology companies to help measure efficacy of new and advanced therapies for one of the world’s most widespread movement disorders.
Aug 2021 – Press release – Global Kinetics Enters Remote Monitoring Business and Appoints New U.S. Commercial Leadership
August 19, 2021 – Global Kinetics Pty Ltd (GK) announced...
Dec 2020 – Thomas Ulmer appointed as Chief Financial Officer
Thomas Ulmer as Chief Financial Officer (CFO), effective April 2021....
GK is committed to supporting customers through the COVID-19 pandemic
As members of the global healthcare community, it is our...
Nov 2019 – PKG Wristwatch Device May Improve Clinical Decision-Making in Parkinson’s, Study Shows
A wrist-worn medical device — called the Personal KinetiGraph or PKG —...
- Global Kinetics Pty Ltd
- Level 9/31 Queen Street Melbourne Australia